Disease Severity and Durability of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Response: A View Through the Lens of the Second Year of the Pandemic
Clin Infect Dis
.
2021 Sep 15;73(6):e1345-e1347.
doi: 10.1093/cid/ciab374.
Author
Liise-Anne Pirofski
1
Affiliation
1
Division of Infectious Diseases, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, USA.
PMID:
33905478
PMCID:
PMC8135546
DOI:
10.1093/cid/ciab374
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
COVID-19*
Humans
Pandemics
SARS-CoV-2*
Severity of Illness Index
Grants and funding
R01 AI143453/AI/NIAID NIH HHS/United States
UL1 TR002556/TR/NCATS NIH HHS/United States
3UL1TR002556-04S1/TR/NCATS NIH HHS/United States
R01AI123654/NH/NIH HHS/United States